查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565149

全球神经义肢市场

Neuroprosthetics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球神经修復术市场预计将达到 252 亿美元

预计 2023 年全球神经修復市场将达到 114 亿美元，预计在 2023 年至 2030 年分析期间将以 12.0% 的复合年增长率增长，并在 2030 年达到 252 亿美元。运动神经元疾病应用是本报告分析的细分市场之一，预计复合年增长率为 13.5%，到分析期结束时将达到 158 亿美元。分析期内认知障碍应用领域的复合年增长率预计为10.9%。

美国市场预估30亿美元，中国预期复合年增长率10.9%

到 2023 年，美国神经修復市场预计将达到 30 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达38亿美元，2023-2030年分析期间复合年增长率为10.9%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 11.1% 和 9.9%。在欧洲，德国的复合年增长率预计为 8.2%。

全球神经修復市场 - 主要趋势和驱动因素总结

什么是神经修復术以及为什么它们具有变革性？

神经假体是先进的医疗设备，可与神经系统连接，恢復或增强因损伤、疾病或先天性疾病而丧失的神经功能。透过向神经系统的特定区域发送电讯号，这些设备可以取代或辅助运动控制、感官知觉甚至认知功能等功能。神经修復术的常见例子包括用于听力恢復的人工电子耳、用于治疗帕金森氏症的深部脑刺激（DBS）设备以及允许瘫痪患者控制机器人肢体的脑机介面等。

神经修復术的变革性在于它们能够帮助严重残疾的人恢復独立并提高生活品质。这些设备为治疗多种神经系统疾病（包括癫痫、中风和脊髓损伤）开闢了新的可能性。随着神经假体技术的不断进步，开发能够与大脑即时互动的更复杂系统的可能性正在成为现实，为世界各地数百万名患者带来了新的希望。

神经修復市场如何发展？

由于材料科学、神经科学和生物技术的进步，神经修復市场正在迅速发展。该市场最重要的趋势之一是开发不需要外部电线或笨重硬体的无线神经假体系统。此类无线设备为患者提供更大的移动性和舒适度，同时降低与有线系统相关的感染风险。此外，神经假体组件的小型化可以与身体无缝集成，从而提高设备的功能和美观性。

另一个重要趋势是机器学习和人工智慧在神经修復术中的使用越来越多。透过结合人工智慧演算法，这些设备可以学习患者的神经模式并适应他们的特定需求，从而提供更个人化和有效的治疗。这对于脑机介面（BCI）来说尤其重要，它依靠脑波讯号的即时分析来控制机器人肢体等外部设备。随着人工智慧技术的进步，神经假体预计将变得更加直观和灵敏，从而进一步增加其对患者生活的影响。

哪些疾病会促进神经修復术的普及？

几种神经系统疾病正在推动神经修復术的采用，其中最着名的是听力损失、帕金森氏症和瘫痪。人工电子耳是使用最广泛的神经义肢假体，正在帮助数百万严重听力损失的人恢復听力。这些设备绕过耳朵受损部分，直接刺激听觉神经，为声音讯号到达大脑提供清晰的途径。

在帕金森氏症的治疗中，深部脑部刺激 (DBS) 设备透过提供控制震颤和僵硬等运动症状的方法，彻底改变了患者护理。 DBS 设备向大脑的特定区域发送电脉衝，以控制异常的神经活动。同样，用于脊髓损伤和瘫痪的义肢假体也变得越来越普遍。这些设备通常与脑机介面结合，使瘫痪患者能够利用他们的思想来操纵机器人肢体和外骨骼，从而使以前无法达到的活动水平得到恢復。

神经假体市场的主要成长动力是什么？

神经修復市场的成长受到多种因素的推动。主要因素之一是听力损失、癫痫、帕金森氏症和脊髓损伤等神经系统疾病的盛行率不断增加。随着世界人口老化，这些疾病的盛行率预计将增加，从而增加对神经修復解决方案的需求。另一个主要驱动力是材料、人工智慧和生物工程的快速进步，这些进步使神经修復术更加有效、更舒适，并且可供更多患者使用。

对个人化医疗的日益关注也推动了市场的发展，矫正器具正在根据个别患者的特定需求进行客製化。此外，神经学研究和开发投资的增加以及医疗设备有利的法规环境正在为创新和市场扩张创造机会。增加公共和私人对神经假体研究（尤其是脑机介面）的资助，正在进一步加速该市场的成长。

受访企业范例（44家知名企业）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • NDI Medical
  • NeuroPace, Inc.
  • Nevro Corp.
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • Sonova Holding AG

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP13580

Global Neuroprosthetics Market to Reach US$25.2 Billion by 2030

The global market for Neuroprosthetics estimated at US$11.4 Billion in the year 2023, is expected to reach US$25.2 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2023-2030. Motor Neuron Disorders Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Cognitive Disorders Application segment is estimated at 10.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 10.9% CAGR

The Neuroprosthetics market in the U.S. is estimated at US$3.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.1% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Neuroprosthetics Market - Key Trends & Drivers Summarized

What Are Neuroprosthetics and Why Are They Transformative?

Neuroprosthetics are advanced medical devices that interface with the nervous system to restore or enhance neurological functions that have been lost due to injury, disease, or congenital conditions. These devices can replace or assist functions such as motor control, sensory perception, and even cognitive functions by sending electrical signals to specific areas of the nervous system. Common examples of neuroprosthetics include cochlear implants for hearing restoration, deep brain stimulation (DBS) devices for Parkinson’s disease, and brain-machine interfaces that enable paralyzed individuals to control robotic limbs.

The transformative nature of neuroprosthetics lies in their ability to restore independence and improve the quality of life for individuals with severe disabilities. These devices have opened new possibilities in treating a wide range of neurological disorders, including epilepsy, stroke, and spinal cord injuries. As advancements in neuroprosthetic technology continue, the potential for developing more sophisticated systems that can interact with the brain in real-time is becoming a reality, offering new hope to millions of patients worldwide.

How Is the Neuroprosthetics Market Evolving?

The neuroprosthetics market is evolving rapidly, driven by advances in materials science, neuroscience, and bioengineering. One of the most significant trends in this market is the development of wireless neuroprosthetic systems that eliminate the need for external wires or bulky hardware. These wireless devices provide greater mobility and comfort for patients, while also reducing the risk of infection associated with wired systems. Additionally, the miniaturization of neuroprosthetic components has enabled more seamless integration with the body, improving both the functionality and aesthetic appeal of the devices.

Another key trend is the increasing use of machine learning and AI in neuroprosthetics. By incorporating AI algorithms, these devices can learn from a patient's neural patterns and adapt to their specific needs, providing more personalized and effective treatment. This is particularly important for brain-computer interfaces (BCIs), which rely on real-time analysis of brain signals to control external devices such as robotic limbs. As AI technology continues to advance, neuroprosthetics are expected to become more intuitive and responsive, further enhancing their impact on patients’ lives.

Which Conditions Are Driving Neuroprosthetic Adoption?

Several neurological conditions are driving the adoption of neuroprosthetics, with the most prominent being hearing loss, Parkinson’s disease, and paralysis. Cochlear implants, the most widely used neuroprosthetic devices, have helped millions of individuals with severe hearing impairments regain the ability to hear. These devices work by bypassing damaged parts of the ear and directly stimulating the auditory nerve, providing a clear path for sound signals to reach the brain.

In the treatment of Parkinson’s disease, deep brain stimulation (DBS) devices have revolutionized patient care by providing a means of controlling motor symptoms such as tremors and rigidity. DBS devices send electrical impulses to specific areas of the brain to regulate abnormal neural activity. Similarly, neuroprosthetic devices for spinal cord injuries and paralysis are gaining traction. These devices, often coupled with brain-computer interfaces, enable paralyzed patients to control robotic limbs or exoskeletons using their thoughts, restoring a level of mobility that was previously unattainable.

What Are the Key Growth Drivers in the Neuroprosthetics Market?

The growth in the neuroprosthetics market is driven by several factors. One of the primary drivers is the increasing prevalence of neurological disorders, including hearing loss, epilepsy, Parkinson’s disease, and spinal cord injuries. As the global population ages, the incidence of these conditions is expected to rise, driving demand for neuroprosthetic solutions. Another major driver is the rapid pace of technological advancements in materials, AI, and bioengineering, which are making neuroprosthetics more effective, comfortable, and accessible to a broader patient population.

The expanding focus on personalized medicine is also pushing the market forward, as neuroprosthetic devices are increasingly being tailored to meet the specific needs of individual patients. Additionally, the growing investments in neurological research and development, along with favorable regulatory environments for medical devices, are creating opportunities for innovation and market expansion. The rise in public and private funding for neuroprosthetic research, particularly in brain-computer interfaces, is further accelerating the growth of this market.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • NDI Medical
  • NeuroPace, Inc.
  • Nevro Corp.
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • Sonova Holding AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neuroprosthetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Neurological Disorders and Disabilities Drives Demand for Neuroprosthetic Devices
    • Advancements in Brain-Computer Interface (BCI) Technology Propel Growth in Neuroprosthetics for Motor Function Rehabilitation
    • Rising Adoption of Cochlear Implants and Auditory Neuroprosthetics Expands Market in Hearing Restoration Applications
    • Increasing Use of Neuroprosthetics for Deep Brain Stimulation (DBS) Strengthens Business Case for Parkinsons and Epilepsy Treatment
    • Growing Integration of AI and Machine Learning in Neuroprosthetics Fuels Innovation in Personalized Rehabilitation Therapies
    • Surge in Demand for Retinal Implants and Visual Neuroprosthetics Expands Opportunities in Vision Restoration Technologies
    • Technological Advancements in Wireless Neuroprosthetics Drive Growth in Wearable and Portable Devices for Neurological Patients
    • Increasing Use of Neuroprosthetics in Spinal Cord Injury Rehabilitation Spurs Demand for Advanced Neural Interface Devices
    • Emerging Focus on Peripheral Nerve Stimulation in Neuroprosthetics Expands Applications in Pain Management and Neuroplasticity
    • Rising Adoption of Neuroprosthetics in the Treatment of Epilepsy and Tremors Expands Market for Brain Stimulation Devices
    • Growing Interest in Neuroprosthetic Solutions for Stroke Recovery Drives Innovation in Brain-Machine Interfaces for Motor Function Restoration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neuroprosthetics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Motor Neuron Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Motor Neuron Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Cognitive Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Physiological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Physiological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • JAPAN
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • CHINA
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: China 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • EUROPE
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Europe 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • FRANCE
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • GERMANY
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Germany 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Italy 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • UNITED KINGDOM
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of World 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030

IV. COMPETITION